Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Clinical trial NCT07064746 · RECRUITING
Trial details
- NCT number
- NCT07064746
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-10
- Primary completion
- 2027-07-10
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.